Philip Chase

Philip Chase

Chief Executive Officer at
Adimab LLC
Health Technology
Consumer Services
Commercial Services

Profile

Philip T.
Chase
is Chief Executive Officer at Adimab LLC since 2022.
Former roles include Director at Invivyd, Inc., Vice President & General Counsel at EPIX Pharmaceuticals, Inc., Chief Corporate Counsel at Transkaryotic Therapies, Inc., Vice President & General Counsel at RenaMed Biologics, Inc., and Vice President-Legal Affairs at Alnylam Pharmaceuticals, Inc. Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at Colby College.

Philip Chase active positions

CompaniesPositionStart
Chief Executive Officer 31/03/2022

Former positions of Philip Chase

CompaniesPositionEnd
INVIVYD, INC. Director/Board Member -
General Counsel -
ALNYLAM PHARMACEUTICALS, INC. General Counsel -
General Counsel -
General Counsel -
See the detail of Philip Chase's experience

Training of Philip Chase

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

9

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Commercial Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology